Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S.

This publication has 21 references indexed in Scilit:

• The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses
  JAMA Pediatrics, 2017
• Predictors of Low Uptake of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Immunization in Privately Insured Women in the United States
  Obstetrics & Gynecology, 2017
• Pertussis vaccination during pregnancy: Antibody persistence in infants
  Vaccine, 2016
• Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis
  Clinical Infectious Diseases, 2016
• Effectiveness of maternal pertussis vaccination in England: an observational study
  The Lancet, 2014
• Immune Responses in Infants Whose Mothers Received Tdap Vaccine During Pregnancy
  The Pediatric Infectious Disease Journal, 2013
• Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
  2013
• Importance of Timing of Maternal Combined Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Immunization and Protection of Young Infants
  Clinical Infectious Diseases, 2012
• Pertussis Hospitalizations Among Infants in the United States, 1993 to 2004
  Pediatrics, 2008
• Pertussis Vaccine Effectiveness Among Children 6 to 59 Months of Age in the United States, 1998–2001
  Pediatrics, 2005